Thyroid cancers are the most common malignancy of the endocrine system in humans. To understand the molecular genetic events underlying thyroid carcinogenesis, we have generated a mouse model that spontaneously develops follicular thyroid carcinoma similar to human thyroid cancer (Thrb PV/PV mouse). This mutant mouse harbors a dominantnegative mutated thyroid hormone receptor b (denoted PV). The PV mutation was identified in a patient with resistance to thyroid hormone (TH). Thrb PV/PV mice exhibit highly elevated serum thyroid-stimulating hormone levels and increased TH. We have previously shown that thyroidstimulating hormone is required, but not sufficient to induce metastatic follicular thyroid cancer in Thrb PV/PV mice. However, whether the elevated TH also contributes to the thyroid carcinogenesis of Thrb PV/PV mice was not elucidated. To understand the role of TH in thyroid carcinogenesis, we blocked the production of TH by treating Thrb PV/PV mice with propylthiouracil (Thrb -PTU mice. Furthermore, matrix metalloproteinase-2, a downstream target of b-catenin and a key regulator during tumor invasion and metastasis, was also decreased. Thus, the present study uncovers a critical role of TH in promoting the thyroid carcinogenesis of Thrb PV/PV mice via membrane signaling events. Importantly, these findings suggest that anti-thyroid drugs could be considered as possible therapeutic agents of thyroid cancer.
Introduction
Thyroid carcinoma, the most common endocrine malignancy, is on the rise worldwide (Davies and Welch, 2006; Rego-Iraeta et al., 2009; Sassolas et al., 2009; Sipos and Mazzaferri, 2010) . Thyroid cancers are mainly follicular cell-derived neoplasms, which include papillary thyroid carcinoma (B80% of thyroid carcinomas), follicular thyroid carcinoma (FTC, o10%), poorly differentiated thyroid carcinoma (B5%) and undifferentiated thyroid carcinoma/anaplastic thyroid carcinoma (o1%) (Nikiforov, 2004; Puxeddu et al., 2011) . Several genomic abnormalities, including gene mutations (for example, rat sarcoma oncogene, RAS and v-raf murine sarcoma viral oncogene homolog B1, BRAF) and genomic rearrangements (for example, rearranged during transfection proto-oncogene/papillary thyroid carcinoma (RET-PTC) and paired box-8/ peroxisome proliferator-activated receptor gamma (PAX8/PPARG) fusion gene), have been associated with thyroid cancers (Nikiforova and Nikiforov, 2009 ). However, how these genetic changes lead to thyroid cancers is not fully understood.
To understand the molecular mechanisms underlying thyroid carcinogenesis, we have created a mouse model (Thrb PV/PV mouse) that spontaneously develops FTC (Kaneshige et al., 2000; Suzuki et al., 2002) . These mutant mice bear a knock-in mutated Thrb gene (Thrb PV ) that encodes TRbPV, which has completely lost thyroid hormone (TH) binding and transcription activity (Kaneshige et al., 2000) . The TRbPV mutant was identified in a patient with resistance to thyroid hormone (Parrilla et al., 1991) . Extensive characterization of altered signaling pathways during thyroid carcinogenesis of the Thrb PV/PV mouse has identified activation of several tumor promoters such as b-catenin, cyclin D1, pituitary tumor transforming gene (PTTG), steroid receptor coactivator-3 (SRC-3) and phosphatidylinositol 3-kinase (PI3K), and the repression of tumor suppressors such as PPARg (Ying et al., 2003 (Ying et al., , 2006 (Ying et al., , 2008 Furuya et al., 2006; Kim et al., 2007; Guigon et al., 2008) . These altered signaling pathways during thyroid carcinogenesis of Thrb PV/PV mice are consistent with the changes reported in human thyroid cancers (Boelaert et al., 2003; Weinberger et al., 2007; Saji and Ringel, 2010) . Thus, the Thrb PV/PV mouse is a valid mouse model to elucidate the molecular mechanisms underlying thyroid carcinogenesis.
Thyroid hormones (T3 and thyroxine, T4) have a critical role in development, growth and differentiation, and in maintaining metabolic homeostasis. They bind to thyroid hormone nuclear receptors (TRa and TRb) to regulate target gene transcription . In addition to mediating genomic actions, increasing lines of evidence also suggest that TH can initiate extranuclear functions through cytosolic thyroid hormone receptors (TRs) and/or via plasma membrane receptors (for example, integrin avb3) (Bergh et al., 2005; Davis et al., 2009) . TH induces proliferation of several cancer cell lines, including breast, brain, pancreas and thyroid (Lin et al., 2007 Verga Falzacappa et al., 2007; Glinskii et al., 2009; Yalcin et al., 2010) . The Thrb PV/PV mouse, similar to a homozygous patient with resistance to thyroid hormone (Ono et al., 1991) , exhibits highly elevated thyroid-stimulating hormone (TSH) in the face of elevated TH (Kaneshige et al., 2000) . Recently, using a mouse-genetics approach, we have clearly demonstrated that TSH signaling is essential, but not sufficient to induce the development of metastatic FTC (Lu et al., 2010) . However, it is unclear whether elevated TH levels also affect the thyroid carcinogenesis of Thrb PV/PV mice. To explore the role of TH in thyroid carcinogenesis, we treated Thrb PV/PV mice with the goitrogen propylthiouracil (PTU) to block TH synthesis. We monitored the spontaneous development of thyroid cancer in these Thrb PV/PV -PTU mice and compared it with that in untreated Thrb PV/PV mice. Here we show that inhibition of TH synthesis by PTU treatment decreased thyroid tumor growth and delayed tumor progression in Thrb PV/PV mice. The decreased tumor cell proliferation was attributed to a marked attenuation of the PTEN-PI3K-AKT signaling pathway, resulting in reduction of cyclin D2 to decrease tumor cell proliferation. Reduction of b-catenin-matrix metalloproteinase-2 (MMP-2) signaling contributed to delayed tumor progression. Thus, the present study shows that TH, via membrane signaling pathways, acts to promote thyroid carcinogenesis in a mouse model of thyroid cancer.
Results
Inhibition of thyroid hormone (TH) production by propylthiouracil (PTU) leads to the inhibition of follicular thyroid carcinoma (FTC) development in Thrb PV/PV mice Our previous studies have shown that the development of FTC in Thrb PV/PV mice requires the TSH proliferation signal, whereas its progression, specifically metastasis, is attributed to the mutated TRb (Lu et al., 2010 . However, whether elevated TH levels also contribute to the thyroid carcinogenesis of Thrb PV/PV mice is unclear. To investigate the role of TH in FTC development in Thrb PV/PV mice, we treated Thrb PV/PV mice with PTU to block TH synthesis starting at 2 months and continuing on the PTU diet until the mice were killed for analyses. To confirm the effect of PTU, we measured serum levels of total T4 (TT4) and TSH in Thrb PV/PV and Thrb PV/PV -PTU mice (Figure 1) . Consistent with the previous report (Kaneshige et al., 2000) , an elevated serum level of TT4 was found in Thrb PV/PV mice ( Figure 1a , TT4 ¼ 19.52±1.44 mg/dl, n ¼ 10), and the TH level was greatly suppressed (Figure 1a , Thrb PV/PV -PTU mice, TT4 ¼ 1.64 ± 0.12 mg/dl, n ¼ 10), even lower than that of wild-type mice (WT; TT4 ¼ 2.51±0.19 mg/dl, n ¼ 28, data not shown in the graph). However, PTU treatment did not affect serum TSH levels of Thrb PV/PV mice, as indicated in Figure 1b , in that no statistically significant differences were detected (8002±2263 ng/ml, n ¼ 10 and 12 790 ± 3506 ng/ml, n ¼ 8 for Thrb PV/PV mice and Thrb PV/PV -PTU, respectively). The first evidence suggesting that TH could have a role in FTC development was the decreased weight of thyroid tumors in Thrb PV/PV -PTU mice. As shown in Figure 1 Comparison of serum levels of TT4 and TSH in Thrb PV/PV mice with or without PTU treatment. Serum TT4 (a) and TSH (b) of Thrb PV/PV (n ¼ 10) and Thrb PV/PV -PTU mice (n ¼ 8-10) at the ages of 8-12 months were determined as described in Materials and methods. P values are indicated. NS, not significant. Inhibition of thyroid hormone production by propylthiouracil treatment decreases proliferation of thyroid tumor cells in Thrb PV/PV mice with no apparent effect on apoptosis Cell proliferation and apoptosis are two major processes that affect tumor growth. To determine which process was responsible for the decreased tumor growth due to the reduction of TH in Thrb PV/PV -PTU mice, we compared the extent of cell proliferation in the thyroids of both groups of mice by bromodeoxyuridine (BrdU) incorporation assay. To perform the assay, mice were intraperitoneally injected with BrdU 2 h before killing. Although no apparent positive signals were detected in the thyroid sections of WT mice ( Figure 3A , panels a and b) under the experimental conditions, nuclei with BrdU incorporation were clearly visualized by immunostaining of thyroid sections of Thrb PV/PV mice (panels c and d) and Thrb PV/PV -PTU mice (panels e and f). However, fewer nuclei with incorporation of BrdU were observed in the treated mice. Sections from small intestine and brain tissue of WT mice were used as controls, representing cells with high and low proliferation rates, respectively ( Figures 3A, g and h) . To quantify the percentage of cells that were undergoing an active cell cycle within a 2-h BrdU-labeling period, we calculated the average ratio of BrdU-positive cells to total cells from 10-12 bright fields at high magnification ( Â 400) of each section. The quantitative data are shown in Figure 3B . In WT mice, less than 1% of thyrocytes underwent DNA replication (Figures 3Aa, b and B), but more than 2.3% of cells from Thrb PV/PV mice were involved in the cell cycle ( Figures 3Ac, d and B). After PTU treatment, this ratio dropped to 1.2% (52% reduction; Figures 3Ae, f and B), indicating a marked reduction in the proliferation of thyroid tumor cells when TH was decreased in Thrb PV/PV -PTU mice. We also determined the effect of TH on apoptosis of thyroid tumor cells in these mice by assessing the abundance of cleaved caspase 3, a marker of apoptosis, by immunohistochemistry. No apparent changes of cleaved caspase 3 staining were found in Thrb PV/PV -PTU thyroid (Figure 3Cb ) as compared with the control group ( Figure 3Ca ). We also measured the protein levels of B-cell lymphoma 2 (Bcl-2), a key regulator in apoptosis, by western blot analysis ( Figure 3D ). Similar protein levels of Bcl-2 were found in thyroid extracts of Thrb PV/PV and Thrb PV/PV -PTU mice. In addition, we further determined the protein levels of other apoptotic regulators, including B-cell lymphoma-extra large (BclxL) and Bcl-2-interacting mediator of cell death (Bim). No apparent changes in protein levels of these apoptotic regulators were detected in Thrb PV/PV mice with or without PTU treatment (data not shown). Thus, consistent with cleaved caspase 3 staining, these results showed that a reduction of TH had no effect on apoptosis of thyroid tumor cells in Thrb PV/PV mice. On the basis of these findings, we concluded that reduced proliferation, but not apoptosis, contributed to the reduced thyroid tumor growth of Thrb PV/PV mice when TH was lowered. Growth-promoting activity of T3 in thyroid cancer C Lu et al Inhibition of thyroid hormone production by propylthiouracil treatment decreases activation of the integrin avb3-AKT signaling pathway in thyroids of Thrb PV/PV mice It has been reported that TH increases proliferation of human thyroid cancer cell lines by activating the integrin avb3-MAPK signal transduction pathways (Lin et al., 2007) . Similar TH effects via these pathways have also been reported in human glioma cell line . To dissect the molecular mechanisms of TH that led to the increased cell proliferation in FTC of Thrb PV/PV mice, we first examined the abundance of TH membrane receptor integrin avb3 at both transcriptional and translational levels. No differences in the mRNA levels were detected for either the Itgav or the Itgb3 gene between Thrb PV/PV and Thrb PV/PV -PTU mice (Supplementary Figures IA and B) . However, western blot analysis showed that the protein level of integrin av was lower in the thyroid tumor extract of Thrb PV/PV -PTU mice than in that of Thrb PV/PV mice ( Figure 4Aa , compare lanes 3 and 4 to lanes 1 and 2). After normalization to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) loading controls (Figure 4Ac ), a 60% decrease of integrin av protein abundance was found in Thrb PV/PV -PTU mice. However, no apparent changes in protein levels of integrin subunit b3 were observed in Thrb PV/PV -PTU mice (Figure 4Ab , compare lanes 3 and 4 with lanes 1 and 2). These results suggest a downregulation of -PTU (lanes 4 and 5) mice. Total extracts were prepared from thyroids of Thrb PV/PV and Thrb PV/PV -PTU mice. Western blot analysis was carried out as described in Materials and methods. Representative results from five to six mice of each group were shown. GAPDH was used as the loading control.
TH membrane receptor in response to decreased TH in thyroid tumor cells of Thrb PV/PV -PTU mice. The PI3K-AKT signaling cascade is a critical pathway reported to be associated with the extranuclear signaling of TH-TRs (Cao et al., 2005; Verga Falzacappa et al., 2007) . Direct association of TRbPV with the regulatory subunit p85a of PI3K activates PI3K-AKT signaling in tumor cells of Thrb PV/PV mice . Accordingly, we addressed the question of whether TH affected the activated AKT by determining the protein abundance of phosphorylated AKT in thyroid tumors of Thrb PV/PV and Thrb PV/PV -PTU mice. Figure 4B shows that AKT phosphorylation was reduced (B33%) in PTU-treated Thrb PV/PV mice (Figure 4Ba, compare lanes 4 and 5 with lanes 1-3) . In contrast to the reduced phosphorylated AKT, no changes in the total amount of AKT protein were detected (Figure 4Bb ). We also determined the phosphorylation status of glycogen synthase kinase 3b (GSK3b), a direct downstream target of AKT. It is known that GSK3b activity is inhibited by AKT phosphorylation, resulting in increased protein synthesis and proliferation in cells (Liang and Slingerland, 2003) . Consistent with decreased activation of AKT (Figure 4Ba ), western blot analysis revealed decreased phosphorylated GSK3b (Figure 4Bc , compare lanes 4 and 5 with lanes 1-3) in thyroid tumors of Thrb PV/PV -PTU mice without any change in total GSK3b protein levels (Figure 4Bd ). Taken together, these results show that the lowering of TH leads to decreased AKT signaling.
Phosphatase and tensin homolog (PTEN) activity is increased in thyroid tumors of Thrb PV/PV -PTU mice Phosphatase and tensin homolog (PTEN) has an essential role in opposing PI3K-AKT activation by negative regulation of the intracellular level of phosphatidylinositol-3,4,5-trisphosphate (PIP3). PTEN is also one of the tumor suppressors frequently lost in human cancers (Keniry and Parsons, 2008) . We therefore assessed the expression of the Pten gene at both the translational and transcriptional levels. Western blot analysis revealed an elevated PTEN protein level (B2.4-fold) in thyroid tumor extracts of Thrb PV/PV -PTU mice (Figure 5Aa, compare lanes 4 and 5 with lanes 1-3) . Using real-time RT-PCR, we determined the Pten mRNA expression in tumors of Thrb PV/PV and Thrb PV/PV -PTU mice. Consistent with the increased protein levels of PTEN, a small (B20%) but significantly elevated Pten mRNA was observed in Thrb PV/PV -PTU mice as compared with Thrb PV/PV mice ( Figure 5B ). These results indicate that decreased TH leads to activated expression of the Pten gene at both the mRNA and protein levels. mice. Total thyroid lysates from six to seven mice of each group were analyzed by western blot analysis as described in Materials and methods. The average ratios of band intensity after normalization were shown under the image. The expression levels of integrins were normalized to the protein amount of loading control, GAPDH. Compared with Thrb PV/PV mice (Aa, lanes 1 and 2), a decrease of integrin av was observed in Thrb PV/PV -PTU mice (lanes 3 and 4), whereas no apparent changes of integrin b3 (Ab) were found. The relative abundance of phosphorylated AKT (p-AKT) or p-GSK3b was normalized to the total protein amount. Reduced p-AKT (Ba, lanes 4 and 5) and p-GSK3b (Bc, lanes 4 and 5) were observed in Thrb PV/PV -PTU mice as compared with Thrb PV/PV mice (lanes 1-3 of Ba and Bc, respectively). No apparent alterations in total protein levels of AKT (Bb) and GSK3b (Bd) were detected.
Growth-promoting activity of T3 in thyroid cancer C Lu et al thereby activating its transcriptional activity to affect bcatenin downstream targets involved in cell proliferation (Fang et al., 2007) . To understand whether b-catenin is the effector of activated AKT signaling in thyroid carcinogenesis, we compared the protein abundance of phosphorylated b-catenin at Ser552 in thyroid tumors between Thrb PV/PV and Thrb PV/PV -PTU mice. Figure 6A Growth-promoting activity of T3 in thyroid cancer C Lu et al mice mimic those observed in human thyroid cancers Ying et al., 2006 Ying et al., , 2008 Guigon et al., 2008; Guigon and Cheng, 2009; Lu et al., 2010) . Thus, the Thrb PV/PV mouse provides us with an unusual opportunity to investigate the role of TH in thyroid carcinogenesis. In Thrb PV/PV mice, the expression of a dominant-negative mutated TRb (that is, PV) results in dysregulation of the pituitary-thyroid axis with elevated TSH in the face of elevated TH (Kaneshige et al., 2000) . To understand how TH affects thyroid carcinogenesis, we treated Thrb PV/PV mice with PTU to block the synthesis of TH. As confirmed by hormone assays, Thrb PV/PV -PTU mice exhibited suppressed serum levels of TT4 as compared with the untreated Thrb PV/PV mice (Figure 1 ). However, PTU had no effect on the synthesis and secretion of TSH given that Thrb PV/PV -PTU mice maintained a TSH level as high as that of Thrb PV/PV mice. The similarly elevated serum levels of TSH would suggest that the thyroids of Thrb PV/PV and Thrb PV/PV -PTU mice received a similar stimulated activity from the TSH-TSH receptor pathway in promoting thyrocyte proliferation. The similarly elevated TSH level led us to conclude that the differences in phenotypes of thyroid tumors found between PTU-treated and untreated Thrb PV/PV mice were mainly conferred by the effects due to changes in TH levels. By decreasing TH levels in Thrb PV/PV mice, we observed reduced growth of thyroid tumors with delayed pathological progression. The reduced tumor size was mainly attributed to the decreased tumor cell proliferation with no changes in apoptotic status (Figures 2 and 3) . Thus, TH acts to stimulate thyroid tumor cell proliferation of Thrb PV/PV mice. To dissect the molecular mechanisms by which TH activated tumor cell proliferation, we focused on the studies of key regulators involved in membrane signaling events. Although TRb is the major TR isoform in the thyroid, we reasoned that in Thrb PV/PV mice the mutant TRb, PV, could no longer mediate TH actions. Moreover, we previously discovered that TRbPV acts not only in a dominant-negative fashion by nucleusinitiated events, but also by extranuclear signaling by activating the PI3K-AKT pathway (Furuya et al., , 2007 , as well as by increasing the stability of b-catenin (Guigon et al., 2008 (Guigon et al., , 2010 , thereby promoting thyroid carcinogenesis in Thrb PV/PV mice ). Accordingly, we ascertained which players in the TRbPV-mediated extranuclear PI3K-AKT pathway were affected by TH. Indeed, we found that the upstream negative regulator of PI3K-AKT signaling, PTEN, was markedly increased when TH was reduced in Thrb PV/PV -PTU mice ( Figure 5 , also see Figure 7 ), leading to an attenuation of PI3K-AKT signaling (Figures 4 and 7) . Consistently, the protein abundance of phosphorylated b-catenin, a critical downstream key effector of PI3K-AKT signaling, was reduced when TH was lowered, leading to reduced cyclin D2 to decrease cell proliferation. Thus, the present study has uncovered an effect of TH that modulates the activity of the PTEN-PI3K-AKT-b-catenin-cyclin D2 pathway to affect the tumor cell proliferation and carcinogenesis of the thyroid of Thrb PV/PV mice.
At present, how TH regulates the expression of the Pten gene is not clear. In addition to an increased protein abundance of PTEN ( Figure 5A ) when TH was lowered, we found a small but significant increase in the mRNA expression of the Pten gene in Thrb PV/PV -PTU mice ( Figure 5B ). One possibility that could be considered to account for the increased expression of the Pten gene protein is by the TH membrane receptor, integrin avb3, reported by Davis and his group (Bergh et al., 2005; Lin et al., 2009; Cheng et al., 2010) . Actions of TH on the integrin avb3 receptor have been demonstrated in many cell types with diverse cellular effects, such as T4-simulated angiogenesis on vessel endothelial cells and enhanced proliferation of tumor cells, including breast cancer, glioblastoma and thyroid cancer cell lines (Davis et al., 2004; Mousa et al., 2006; Glinskii et al., 2009; Lin et al., 2009 ). The present study showed decreased protein abundance of integrin subunit av, albeit with no changes of b3 protein levels when TH was lowered in Thrb PV/PV -PTU mice ( Figure 4A ). It is possible that the expression of the Pten gene is affected by dampening integrin avb3 signaling, followed by relaying the signals via MAPK phosphorylation cascades (Bergh et al., 2005; Lin et al., 2007) to reach the ultimate downstream nuclear events (yet to be identified). However, this possibility awaits future studies to be tested and validated.
The data from the present molecular study led us to propose a model (see Figure 7 ) that supports the contention that one mechanism by which TH acted was by integrin-mediated extranuclear signaling. TRb is the major TR isoform in the thyroid, and is mutated to PV that cannot bind TH in Thrb PV/PV mice. However, at present, we could not exclude the possibility that TH thyroid tumor cells, TRbPV directly interacts with PI3K to activate AKT signaling pathway . By suppression of TH in these cells, the membrane receptor integrin avb3 was downregulated. In addition, the PTEN activity was activated, which decreased the formation of PIP3. The reduction of PIP3 decreased the p-AKT and its downstream b-catenin and GSK3b signaling cascades to inhibit cell proliferation. The solid arrows indicate the direction of signaling cascade. The broken arrows mark the up and down changes.
Growth-promoting activity of T3 in thyroid cancer C Lu et al could potentially mediate its proliferative effects by TRa1-initiated nuclear genomic signaling events. However, PV is known to be a potent dominant-negative mutant (Parrilla et al., 1991; Kaneshige et al., 2000) . The possibility exists that it could also act to interfere with the transcription activity of TRa1. However, at present, no data are available to clarify the role of TRa1 in mediating TH effects in the thyroid of Thrb PV/PV mice. Association studies have shown that amplification of the PIK3CA gene and aberrant activation of AKT are frequent in human thyroid cancer (Hou et al., 2007; Saji and Ringel, 2010; Xing, 2010) , demonstrating the crucial role of PI3K-AKT signaling in thyroid carcinogenesis. Recently, using a mouse model of FTC in which two alleles of the Pten gene were selectively deleted in the thyroid, Antico-Arciuch et al. (2010) showed a direct role of estrogens in increasing thyrocyte proliferative index by crosstalk with the PI3K pathway. The present study identified TH as a critical hormonal stimulator to promote thyroid carcinogenesis of Thrb PV/PV mice by regulating the PI3K-AKT signaling. The present data have shown that TH acts to promote tumor cell proliferation by PI3K-AKT-b-catenin-cyclin D2 signaling. In view of these findings, anti-thyroid drugs could be considered as potential therapeutic agents for the treatment of thyroid cancer.
Materials and methods

Mouse strain
All aspects of animal care and experimentation were approved by the National Cancer Institute Animal Care and Use Committee. Thrb PV/PV mice used in the present study were the offspring of many generations of intersibling mating over 6 years (more than 30 generations). For the PTU treatment group, Thrb PV/PV mice were fed an iodine-deficient diet supplemented with 0.15% PTU (cat. no.; TD.95125, Harlan Laboratories, Inc., Indianapolis, IN, USA) beginning at the age of 2 months and continuing on the PTU diet until the mice were killed for analyses. Control group mice were fed a normal mouse diet. Moribund mutant mice and PTU-treated littermates were euthanized to harvest tissues for weighing, histological analysis and biochemical studies.
Determination of serum levels of total T4 and thyroidstimulating hormone by radioimmunoassay Blood was collected from the mice before killing. The serum level of TT4 was determined by using a Gamma Coat T4 assay radioimmunoassay kit (Dia-Sorin, Stillwater, MN, USA) according to the manufacturer's instructions. TSH levels in serum were measured as previously described (Kaneshige et al., 2000) .
Histology and immunohistochemistry
For histological evaluation, thyroid glands were fixed in 10% neutral-buffered formalin and subsequently embedded in paraffin. Five-mm-thick sections were prepared and stained with hematoxylin and eosin for histopathological analysis. Immunohistochemistry was also performed with paraffin sections by standard methods. In brief, de-waxed sections were processed using 0.05% citraconic anhydride buffer (pH 7.4) at 98 1C for 45 min to expose the antigen epitopes. The primary antibody, rabbit anti-cleaved caspase 3 antibody (1:50 dilution, Cell Signaling Technology, Danvers, MA, USA), was incubated with tissues overnight at 4 1C. Peroxidase activity from the secondary antibody was detected by adding substrate 3,3 0 -diaminobenzidine, and the sections were counterstained with hematoxylin.
Bromodeoxyuridine incorporation assay
To measure the thyrocyte proliferation rate, the BrdU incorporation assay was performed. In brief, mice were injected intraperitoneally with BrdU at 50 mg/g of body weight and then killed 2 h after the injection. Tissues were processed and immunohistochemistry was performed on paraffin sections as described above with some modifications. Briefly, dewaxed slides were treated with Antigen Unmasking solution (Vector Laboratories, Burlingame, CA, USA) in the microwave for 20 min after boiling, and stained with mouse antiBrdU antibody (1:10 dilution, Cat. no.; 347589, Becton Dickinson Immunocytometry Systems, San Jose, CA, USA) overnight at 4 1C. The quantification of BrdU-positive cells was performed on digital images captured under Â 400 magnification of each thyroid section. Two randomly selected slides from three thyroids of each group were analyzed. For each slide, ratios of BrdU-positive cells/total cells from 10-12 bright fields under Â 400 amplification were calculated.
Western blot analysis
Protein extracts from thyroids dissected from Thrb PV/PV and Thrb PV/PV -PTU mice were prepared as described previously (Lu et al., 2010) . About 30-40 mg of protein extract was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the western blot analysis was carried out (Furumoto et al., 2005) . Primary antibodies for phosphorylated-Ser473-AKT, total AKT, p-Ser21/9-GSK-3a/b, total GSK-3b, p-Ser552-bcatenin, p-Ser33/37/Thr41-b-catenin, total b-catenin, cleaved caspase 3, cyclin D2 and GAPDH were purchased from Cell Signaling Technology. Antibodies for integrin av, integrin b3 and MMP-2 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Quantitative real-time RT-PCR Total RNA from five to seven mouse thyroids in each experimental group was extracted by TRIzol (Invitrogen, Carlsbad, CA, USA), followed by RNase-free DNase treatment (Qiagen, Valencia, CA, USA) and column purification (RNeasy Mini Kit, Qiagen). 
Statistical analysis
All data of radioimmunoassays were expressed as mean± s.e.m. The statistical analyses on these data were performed using a one-way analysis of variance followed by Bonferroni's post hoc test for multiple comparisons (Prism, GraphPad, San Diego, CA, USA). Po0.05 was considered as statistically significant. For western blot results, films were scanned and the intensity of each band was quantified by ImageJ Analysis Software (NIH, Bethesda, MD, USA). Data were normalized against GAPDH or calculated as a ratio between phosphorylated and total protein levels. For real-time RT-PCR, the Gapdh gene expression was used as an internal control. The statistical analysis was performed using an unpaired t-test by Prism software (GraphPad). Po0.05 was considered as statistically significant.
